Sources of the figures for North Macedonia
| Source | Type | Rows | Indicators | Years | Read from | Retrieved |
|---|---|---|---|---|---|---|
| UNAIDS AIDSinfo | Modelled estimate | 561 | 22 | 2000–2024 | aidsinfo.unaids.org | 2026-10-20 |
| WHO Global Tuberculosis Programme | Programme record | 82 | 6 | 2000–2024 | extranet.who.int | 2026-10-16 |
| World Bank Open Data | Modelled estimate | 51 | 2 | 2000–2025 | api.worldbank.org | 2026-10-12 |
| IATI, through d-portal | Expenditure account | 41 | 3 | 2000–2026 | d-portal.org | 2026-10-12 |
| WHO Global Health Expenditure Database | Expenditure account | 38 | 7 | 2016–2021 | apps.who.int | 2026-10-12 |
| OECD Creditor Reporting System | Expenditure account | 36 | 3 | 2002–2021 | sdmx.oecd.org | 2026-10-12 |
| ForeignAssistance.gov | Expenditure account | 10 | 2 | 2003–2013 | foreignassistance.gov | 2026-10-29 |
| Global Fund Data Service | Programme record | 9 | 5 | 2017 | fetch.theglobalfund.org | 2026-10-12 |
| HIV/AIDS surveillance in Europe 2025, the joint report of ECDC (the European Centre for Disease Prevention and Control) and the WHO Regional Office for Europe, Tables 1 and 13 | Programme record | 8 | 1 | 2017–2024 | ecdc.europa.eu | 2026-10-21 |
| UNAIDS Global AIDS Monitoring expenditure database | Expenditure account | 7 | 7 | 2019 | hivfinancial.unaids.org | 2026-10-12 |
| WHO HIV testing services dashboard | Programme record | 6 | 4 | 2018–2019 | eic-database-290813.ew.r.appspot.com | 2026-10-14 |
| UNAIDS Data 2025 country databook | Expenditure account | 2 | 2 | 2019 | aidsinfo.unaids.org | 2026-10-15 |
| WHO Europe Health for All database | Programme record | 2 | 1 | 2017–2018 | dw.euro.who.int | 2026-10-21 |
Indicators held
| Indicator | Domain | Unit | Rows | Years | Sources | Most recent value |
|---|---|---|---|---|---|---|
| Country-reported HIV expenditure, all sources | Financing | USD | 2 | 2019 | UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database | $2.3m (2019) |
| Domestic public HIV expenditure | Financing | USD | 2 | 2019 | UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database | $2.2m (2019) |
| External HIV and STD spending, national health accounts | Financing | USD | 5 | 2016–2020 | WHO Global Health Expenditure Database | $0 (2020) |
| External HIV financing (all donors, ODA) | Financing | USD | 20 | 2002–2021 | OECD Creditor Reporting System | $930 (2021) |
| External HIV financing from governments other than the United States (IATI) | Financing | USD | 20 | 2000–2025 | IATI, through d-portal | $0 (2025) |
| External HIV financing from multilateral bodies other than the Global Fund (IATI) | Financing | USD | 7 | 2020–2026 | IATI, through d-portal | $13k (2026) |
| External HIV financing from the United States (ODA) | Financing | USD | 7 | 2003–2013 | ForeignAssistance.gov, OECD Creditor Reporting System | $-5 (2013) |
| Global Fund HIV disbursements to the country | Financing | USD | 29 | 2004–2019 | IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database | $110k (2019) |
| Government HIV and STD spending as a share of government health spending | Financing | percent | 6 | 2016–2021 | WHO Global Health Expenditure Database | 0.4% (2021) |
| Government HIV and STD spending, national health accounts | Financing | USD | 6 | 2016–2021 | WHO Global Health Expenditure Database | $2.4m (2021) |
| HIV and STD spending as a share of all external health spending | Financing | percent | 3 | 2016–2018 | WHO Global Health Expenditure Database | 92.5% (2018) |
| HIV and STD spending as a share of all health spending | Financing | percent | 6 | 2016–2021 | WHO Global Health Expenditure Database | 0.2% (2021) |
| HIV and STD spending, national health accounts | Financing | USD | 6 | 2016–2021 | WHO Global Health Expenditure Database | $2.4m (2021) |
| HIV spending on governance and sustainability | Financing | USD | 1 | 2019 | UNAIDS Global AIDS Monitoring expenditure database | $110k (2019) |
| HIV spending on prevention | Financing | USD | 1 | 2019 | UNAIDS Global AIDS Monitoring expenditure database | $1.4m (2019) |
| HIV spending on treatment, care and support | Financing | USD | 1 | 2019 | UNAIDS Global AIDS Monitoring expenditure database | $759k (2019) |
| International HIV expenditure (country-reported) | Financing | USD | 2 | 2019 | UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database | $110k (2019) |
| Private HIV and STD spending, national health accounts | Financing | USD | 6 | 2016–2021 | WHO Global Health Expenditure Database | $31k (2021) |
| US HIV disbursements managed by USAID | Financing | USD | 5 | 2003–2013 | ForeignAssistance.gov | $-5 (2013) |
| % of ALL PLHIV who are virally suppressed | Treatment cascade | percent | 8 | 2017–2024 | UNAIDS AIDSinfo | 56.0% (2024) |
| % of PLHIV on ART (second 95, PLHIV base) | Treatment cascade | percent | 16 | 2010–2024 | UNAIDS AIDSinfo | 59.0% (2024) |
| % of PLHIV who have been diagnosed (first 95) | Treatment cascade | percent | 17 | 2010–2024 | UNAIDS AIDSinfo | 68.0% (2024) |
| % of estimated HIV-positive incident TB cases on TB treatment and ART | Treatment cascade | percent | 16 | 2003–2024 | UNAIDS AIDSinfo | 0.1% (2024) |
| % of people newly enrolled in HIV treatment diagnosed with TB disease | Treatment cascade | percent | 3 | 2017–2019 | UNAIDS AIDSinfo | 0.4% (2019) |
| % of people newly enrolled in HIV treatment started on TB preventive therapy | Treatment cascade | percent | 3 | 2014–2019 | UNAIDS AIDSinfo | 2.5% (2019) |
| % of returned HIV test results that were positive | Treatment cascade | percent | 2 | 2019 | UNAIDS AIDSinfo, WHO HIV testing services dashboard | 0.2% (2019) |
| HIV tests performed at a health facility | Treatment cascade | count | 2 | 2018–2019 | WHO HIV testing services dashboard | 38,128 (2019) |
| HIV tests performed through community outreach | Treatment cascade | count | 2 | 2018–2019 | WHO HIV testing services dashboard | 2,468 (2019) |
| HIV tests performed with the result returned to the person | Treatment cascade | count | 3 | 2017–2019 | Global Fund Data Service, UNAIDS AIDSinfo, WHO HIV testing services dashboard | 40,596 (2019) |
| HIV-exposed infants tested within two months of birth | Treatment cascade | percent | 1 | 2019 | UNAIDS AIDSinfo | 61.0% (2019) |
| HIV-positive TB patients started or continued on ART | Treatment cascade | count | 9 | 2015–2024 | WHO Global Tuberculosis Programme | 0 (2024) |
| Key-population people tested for HIV (count over the period) | Treatment cascade | count | 3 | 2017 | Global Fund Data Service | By population group, sex or age only, to 2017 |
| New HIV diagnoses with a CD4 count below 200 | Treatment cascade | percent | 3 | 2017–2019 | UNAIDS AIDSinfo | 18.0% (2019) |
| Notified HIV cases, national case surveillance | Treatment cascade | count | 10 | 2017–2024 | HIV/AIDS surveillance in Europe 2025, the joint report of ECDC (the European Centre for Disease Prevention and Control) and the WHO Regional Office for Europe, Tables 1 and 13, WHO Europe Health for All database | 53 (2024) |
| Number of people on ART (PEPFAR MER TX_CURR) | Treatment cascade | count | 16 | 2010–2024 | Global Fund Data Service, UNAIDS AIDSinfo | 500 (2024) |
| People newly enrolled on ART during the year | Treatment cascade | count | 3 | 2017–2019 | WHO Global Tuberculosis Programme | 280 (2019) |
| Pregnant women with HIV who received ARVs for PMTCT | Treatment cascade | count | 15 | 2010–2024 | UNAIDS AIDSinfo | 1 (2024) |
| TB patients recorded as HIV-positive | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 0 (2024) |
| TB patients with an HIV test result recorded | Treatment cascade | count | 11 | 2015–2024 | Global Fund Data Service, WHO Global Tuberculosis Programme | 80 (2024) |
| AIDS-related deaths | Epidemic estimates | count | 125 | 2000–2024 | UNAIDS AIDSinfo | 100 (2024) |
| Deaths from TB among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 0 (2024) |
| HIV prevalence among a key population | Epidemic estimates | percent | 4 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| HIV prevalence, ages 15-49 | Epidemic estimates | percent | 50 | 2000–2024 | UNAIDS AIDSinfo, World Bank Open Data | 0.1% (2024) |
| Incident TB cases among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 1 (2024) |
| New HIV infections | Epidemic estimates | count | 125 | 2000–2024 | UNAIDS AIDSinfo | 100 (2024) |
| People living with HIV | Epidemic estimates | count | 125 | 2000–2024 | UNAIDS AIDSinfo | 740 (2024) |
| Key-population members reached by prevention programmes | Prevention and outreach | percent | 3 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| Key-population people reached by outreach (count over the period) | Prevention and outreach | count | 3 | 2017 | Global Fund Data Service | By population group, sex or age only, to 2017 |
| Estimated size of a key population | Population denominators | count | 4 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| Total population | Population denominators | count | 26 | 2000–2025 | World Bank Open Data | 1,820,909 (2025) |
Every row shown on the North Macedonia page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.
Turn your phone to read the chart upright